Fischer Medical Ventures LimitedFISCHERNSE
Fischer Medical Ventures approves investment in rights issues of three wholly owned subsidiaries
As filed · Fischer Medical Ventures Limited has informed the Exchange regarding Outcome of Board Meeting held on September 24, 2026.
CapitalMixedMinormateriality 48 out of 100
What happened
FactThe board approved a proposal for Fischer Medical Ventures to subscribe to rights issues by its three wholly owned material subsidiaries, subject to applicable terms and laws. The subsidiaries’ disclosed issue terms include 15,603 shares at ₹7,370.25 each for Time Medical International Ventures, 1,507 shares at ₹82,943.48 each for Flynncare Health Innovations, and 53 shares at ₹48,83,552.64 each for FMV Global Innovation.
Why it matters
CapitSignal interpretationExisting holders can maintain their stake only by putting in more money; those who do not subscribe are diluted.
Watch next
Fact- Rights ratio and issue price
- Record date and subscription window
- Promoter intention to subscribe
- The Company is estimating the program value to be over USD 10 million with an implementation plan over 2 years (management committed by FY27)
Evidence
How CapitSignal classified this
- Reasoning:
- The approval indicates planned capital deployment into three wholly owned material subsidiaries, but the filing does not disclose the company’s total subscription amount or funding source. The transactions are described as related-party transactions undertaken at arm’s length and supported by a valuation report.
- Matched on:
- the filing's own subject line
- Confidence in the event type:
- 75%